Wird geladen...
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
Recently, interactions between thrombopoietin (TPO) and its receptor, the myeloproliferative leukemia (MPL) virus oncogene, have been shown to play a role in the development and progression of myeloproliferative neoplasms including myelofibrosis (MF). These observations have led to the development o...
Gespeichert in:
Veröffentlicht in: | Blood |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
American Society of Hematology
2016
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4929928/ https://ncbi.nlm.nih.gov/pubmed/27114459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-10-674465 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|